Clinical Trials Browser

Phase 1 × Terminated × Solid Tumor × Clear all

NCT05100251 2026-02-17

Clinical Trial of WBC100 on Advanced Solid Tumor

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT06299761 2026-01-16

STARMAP

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT03770494 2025-11-04

A Study of LY3405105 in Participants With Advanced Cancer

Phase 1 Terminated

54 enrolled 26 charts

Other solid neoplasm

Solid Tumor

NCT04242147 2025-09-16

A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of KD033 (SAR445710) in Subjects With Metastatic or Locally Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT04249843 2025-09-11

Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT06535009 2025-06-04

Study of ONO-7914 Alone and in Combination With ONO-4538 in Patients With Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT05192174 2025-05-23

Study of NIB101 in Participants With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT05494762 2025-05-01

Safety, Pharmacokinetics, and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab (BGB-A317) in Participants With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT04013217 2025-04-13

Evaluate Eribulin ORA in Subjects With Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT04675996 2024-02-08

First-in-Human Study of INT-1B3 in Patients With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT03928314 2023-12-15

Study of ORIC-101 in Combination With Anticancer Therapy

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT05120375 2023-10-11

Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients in China

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT03139370 2023-08-25

Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced Cancers

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT03588039 2023-05-19

Study of Oraxol and Pembrolizumab in Subjects With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT03894540 2022-09-13

Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours

Phase 1 Terminated

22 enrolled 27 charts

Other solid neoplasm

Solid Tumor

NCT03182673 2022-09-01

The Study of SHR7390 in Combination With SHR-1210 and SHR3162 in Patients With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT04810208 2021-12-30

Intratumoural Injection of a Novel NanoZolid®-Docetaxel Depot Formulation in Patients With Advanced Solid Tumours

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT03752177 2021-10-22

A Study of LY3415244 in Participants With Advanced Solid Tumors

Phase 1 Terminated

12 enrolled 13 charts

Other solid neoplasm

Solid Tumor

NCT04111445 2021-09-10

Study of ADG116 in Patients With Advanced/Metastatic Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT03471286 2021-08-26

A Window of Opportunity Study to Investigate Mechanisms of Actions of Novel Therapeutic Agents in Patients With Resectable Solid Tumor Malignancies

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT02737072 2019-08-12

A Study of LY2510924 and Durvalumab in Participants With Solid Tumors

Phase 1 Terminated

9 enrolled 13 charts

Other solid neoplasm

Solid Tumor

NCT02966171 2018-11-21

A Dose Escalation Study to Assess the Safety and Tolerability of HMPL-453 in Patients With Advanced Solid Malignancies

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT02593708 2017-11-17

Phase1 of Neratinib+Trastuzumab, Pertuzumab, Paclitaxel in Patients With Advanced Solid Tumors/HER2+

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT02049281 2015-02-10

A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011)

Phase 1 Terminated

Other solid neoplasm

Solid Tumor